Skip to Main

Search

Results 981 to 988 of 988 for ""

UTSW researchers document “infodemic” of false information on COVID-19 in first year of pandemic : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/august-infodemic-false-information-covid-19.html

More than 225,000 tweets with the hashtags #scamdemic and #plandemic led to an “infodemic” of misinformation and disinformation on Twitter during the first year of the pandemic, according to a study by UT Southwestern researchers published in PLOS ONE.

UT Southwestern No. 1 hospital in Dallas-Fort Worth, Best Hospital rankings show: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/july-us-news-best-hospital.html?utm_source=facebook&utm_medium=organic&utm_campaign=newsroom&utm_content=usnwrrankings&utm_utm-audience=na&fbclid=IwAR3tY4r24j2gT-WKC5ar4jpT51bBLwVrirgZfpXOMV_c4aSikMhT6vdPJaI

UT Southwestern Medical Center is the No. 1 hospital in Dallas-Fort Worth – the nation’s fourth-largest metro area – for the sixth consecutive year and ranks among the top hospitals nationally in nine specialties ranging from brain to heart to cancer care.

UT Southwestern develops nanotherapeutic to ward off liver cancer: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/nanotherapeutic-to-ward-off-liver-cancer.html?fbclid=IwAR0BcDOWp2UKETuoDkae2IlTo3yQAJ0QALlP2trZNCiZweKoRKBNOeGYBmk

Physician researchers from UT Southwestern Medical Center have developed an innovative nanotherapeutic drug that prevents cancer from spreading to the liver.

UT Southwestern nearly doubles lifespan of mice with brain cancer: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/brain-cancer.html?utm_source=SCCC+Updates+Master+Distribution+List&utm_campaign=e1b4880a1d-EMAIL_CAMPAIGN_2020_02_14_02_00&utm_medium=email&u

UT Southwestern Simmons Cancer Center researchers have developed technology that is spawning a much better form of drug delivery for gene therapy and has achieved a 43 percent increase in the survival of mice with glioblastoma, one of the deadliest forms of human brain cancer.

Three drugs target resistant breast cancers driven by HER2 mutations

https://www.utsouthwestern.edu/newsroom/articles/year-2023/nov-triple-therapy-her2.html

A targeted therapy using three different drugs significantly delayed progression and extended survival for breast cancer patients whose HER2 gene is mutated.

Clinical trial shows stereotactic radiation extends systemic therapy and slows kidney cancer progression : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/stereotactic-radiation-extends-systemic-therapy.html?fbclid=IwAR1nJaYKEYszHNEC8pwRgLaWmvicsg9TfaXSGeHYzFW8nJWsvZ4SctcKXnw

A new study by the Kidney Cancer Program (KCP) at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center shows that highly focused radiation to isolated metastases that progress despite drug therapy can prolong drug use in kidney cancer patients, saving the few other drugs for treating kidney cancer for future use.

Factors inherent to obesity could increase vulnerability to COVID-19: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/obesity-covid19.html

Conditions related to obesity, including inflammation and leaky gut, leave the lungs of obese patients more susceptible to COVID-19 and may explain why they are more likely to die from the disease, UTSW scientists say in a new article published online in eLife.

Revised clinical trial rules during COVID-19 pandemic may benefit patients, survey shows: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/revised-clinical-trial-rules-during-covid-19.html

The COVID-19 pandemic has led to new rules and expectations for clinical trials.